论文部分内容阅读
食管静脉曲张破裂出血是肝硬化门脉高压症的严重并发症,其病死率达9.5％,而再次出血时,病死率高达60％以上,目前对此尚无满意的治疗方法。近年来开展了经内镜注射硬化剂进行止血,但由于曲张静脉内压力高,硬化剂注射退针时穿刺处经常发生明显的喷血或涌血,导致视野不清,甚至由于大量出血而被迫中止治疗。为了减少硬化剂注射针孔出血,我们于1993年6月至1995年2月间,对22例食管静脉曲张破裂出血病人,在硬化剂注射前后给予奥曲肽治疗,观察其控制食管静脉曲张出血及减少硬化剂注射针孔出血的作用,并与20例单纯硬化剂治疗者进行比较,报告如下.
Esophageal variceal bleeding is a serious complication of cirrhosis and portal hypertension, the mortality rate of 9.5%, while bleeding again, the mortality rate as high as 60% or more, at this time there is no satisfactory treatment. In recent years, carried out by endoscopic injection of hardener to stop bleeding, but due to varicose vein pressure, needle retraction needle hardening often obvious spurting or Yong bleeding, resulting in unclear field of vision, or even due to massive bleeding was Forced to stop treatment. In order to reduce the needle hole bleeding sclerosing agent, we in June 1993 to February 1995, 22 cases of esophageal variceal bleeding patients before and after the sclerotherapy given octreotide, observe its control of esophageal variceal bleeding and reduce Sclerotherapy needle hole bleeding, and with 20 cases of simple sclerotherapy were compared, the report is as follows.